Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
企業コードSNOA
会社名Sonoma Pharmaceuticals Inc
上場日Jan 26, 2007
最高経営責任者「CEO」Trombly (Amy)
従業員数168
証券種類Ordinary Share
決算期末Jan 26
本社所在地5445 Conestoga Court, Suite 150
都市BOULDER
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号80301
電話番号18007599305
ウェブサイトhttps://sonomapharma.com/
企業コードSNOA
上場日Jan 26, 2007
最高経営責任者「CEO」Trombly (Amy)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし